Pharmacokinetics of tinidazole in Chinese subjects: Comparison of Mongolian, Korean, Hui, Uighur and Han nationalities

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 12, Issue 2, 2009, Pages 175-180

  Chang, Xin Yu ^a   Guo, Tao ^b   Xia, Dong Ya ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b SHENYANG NORTHERN HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TINIDAZOLE; ANTITRICHOMONAL AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHINESE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; ETHNIC DIFFERENCE; FEMALE; HAN; HUI; HUMAN; HUMAN EXPERIMENT; KOREAN; MALE; MAXIMUM PLASMA CONCENTRATION; MONGOLIAN; NORMAL HUMAN; PHARMACOKINETICS; RACE; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; UIGHUR; UNSPECIFIED SIDE EFFECT; ASIAN; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ETHNOLOGY; HALF LIFE TIME; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; ANTITRICHOMONAL AGENTS; AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; HALF-LIFE; HUMANS; MALE; TINIDAZOLE; YOUNG ADULT;

EID: 70349306421     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3kk50     Document Type: Article

References (24)

1. Nord CE, Kager L. Tinidazole--microbiology, pharmacology and efficacy in anaerobic infections. Infection, 1983; 11: 54-60.
2. Gordts B, Hemelhof W, Asselman C, Butzler JP. In vitro susceptibilities of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal agents. Antimicrob Agents Chemother, 1985; 28: 378-380.
3. Sears SD, O'Hare J. In vitro susceptibility of Trichomonas vagina is to 50 antimicrobial agents. Antimicrob Agents Chemother, 1988; 32: 144-146.
4. Dhar KK, Dhall GI, Ayyagari A. Tinidazole prophylaxis in elective abdominal hysterectomy. IntJ Gynecol Obstet, 1993; 42: 121-125.
5. Karhunen M, Koskela O, Teisala K, Suikkari AM, Mattila J.: Prophylaxis and treatment of anaerobic infections following caesarean section with tinidazole. Chemotherapy, 1985; 31: 228-36.
6. Laitinen S, Ståhlberg M, Kairaluoma MI. Tinidazole prophylaxis in elective colorectal surgery. Scand J Gastroenterol, 1984; 19: 1027-1030.
7. Mitchell DA, Morris TA.: Tinidazole or pivampicillin in third molar surgery. Int J Oral Maxillofac Surg, 1987; 16: 171-174.
8. Wood BA, Faulkner JK, Monro AM. The pharmacokinetics, metabolism and tissue distribution of tinidazole. J Antimicrob Chemother, 1982; 10 (Suppl A): 43-57.
9. Viitanen J, Haataja H, Mannisto PT. Concentrations of metronidazole and tinidazole in male genital tissues. Antimicrob Agents Chemother, 1985; 28: 812-814.
10. Männistö P, Karhunen M, Mattila J, Koskela O, Suikkari AM, Heinonen P, Tuimala R, Haataja H. Concentrations of metronidazole and tinidazole in female reproductive organs after a single intravenous infusion and after repeated oral administration. Infection, 1984; 12: 197-201.
11. Li XQ, Bjorkman A, Andersson TB, Gustafsson LL, Masimirembwa CM. Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data. EurJ Clin Pharmacol, 2003; 59: 429-442.
12. Wood SG, John BA, Chasseaud LF, Brodie RR, Baker JM, Faulkner JK, Wood BA, Darragh A, Lambe RF. Pharmacokinetics and metabolism of 14C-tinidazole in humans. J Antimicrob Chemother, 1986; 17: 801-809.
13. Li GC, Chen Y, Chen W, Wang YH. Study on the phenotype in the metabolic polymorphism of dextromethorphan in Han, Uighur, Hasake nationalities. Chin J Clin Pharmacol, 2004; 20: 104-108.
14. Li GC, Chen CY, Wang YH. Comparative pharmacokinetic study on ciprofloxacin in healthy volunteers of the Han, Uigur and Kazak nationalities. Chin J Clin Pharmacol, 1997; 13: 145-148.
15. He P, Liu GX, Liu ZH, Sun FY, Li CY, Yang Y. Ethnic differences in disposition of antipyrine and acetaminophen between Tibetan and Han healthy volunteers. Acta Pharmaceutica Sinica, 1994; 29: 566-569.
16. Chang XY, Xia DY, Guo T. Determination of contents of tinidazole in blood plasma by HPLC. Chin J Clin Pharm, 2007; 16: 382-384.
17. Chen ZY, Sun RY. DAS software for pharmacological calculation. Chin J Clin Pharmacol Therapeutics, 2002; 7: 562-564.
18. SPSS Inc. SPSS Base User Guide 11.0. Chicago Illinois SPSS Inc, 2001.
19. Liu QG, Zhang FL. Application of SPSS in medical science. Inner Mongolia University Publishing House, 2002; 9: 75-80.
20. Johnson JA. Predictability of the effects of race or ethnicity on pharmacokinetics of drugs. Int J Clin Pharmacol Ther, 2000; 38: 53-60.
21. Yu MS, Qiu XF, Xue JL, Liu ZD, Tan JZ, Li HJ, Liu DX, Li L, Yu WZ, Tang XZ, Zhou MR. Study on the mtDNA polymorphism in Han, Urghur, Hasake and Hui nationalities. Science in China, Ser. B, 1988; 18: 60-70.
22. Ao TM, Zhang GL, Yuan YD, Du RF. Genetic distances estimated on the basis of HLA. Acta Anthropoloqica Sinica, 1984; 3: 166-169.
23. Teishi T, Watanabe M, Nakura H, Asoh M, Shirai H, Mizorogi Y. CYP3A activity in European American and Japanese men using midazolam as an in vivo probe. Clin Pharmacol Ther, 2001; 69: 333-339.
24. M. K, Johnson JA, Derendorf H. Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms. J Clin Pharmacol, 2004; 44: 1083-1105.